Plasma apolipoprotein O level increased in the patients with acute coronary syndrome

Apolipoprotein (apo) O is a novel apolipoprotein that is present predominantly in high density lipoprotein (HDL). However, overexpression of apoO does not impact on plasma HDL levels or functionality in human apoA-I transgenic mice. Thus, the physiological function of apoO is not yet known. In the p...

Full description

Bibliographic Details
Main Authors: Bi-lian Yu, Chen-lu Wu, Shui-ping Zhao
Format: Article
Language:English
Published: Elsevier 2012-09-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520418371
_version_ 1818732520701689856
author Bi-lian Yu
Chen-lu Wu
Shui-ping Zhao
author_facet Bi-lian Yu
Chen-lu Wu
Shui-ping Zhao
author_sort Bi-lian Yu
collection DOAJ
description Apolipoprotein (apo) O is a novel apolipoprotein that is present predominantly in high density lipoprotein (HDL). However, overexpression of apoO does not impact on plasma HDL levels or functionality in human apoA-I transgenic mice. Thus, the physiological function of apoO is not yet known. In the present study, we investigated relationships between plasma apoO levels and high-sensitive C-reactive protein (hs-CRP) levels, as well as other lipid parameters in healthy subjects (n = 111) and patients with established acute coronary syndrome (ACS) (n = 50). ApoO was measured by the sandwich dot-blot technique with recombinant apoO as a protein standard. Mean apoO level in healthy subjects was 2.21 ± 0.83 µg/ml whereas it was 4.94 ± 1.59 µg/ml in ACS patients. There were significant differences in plasma level of apoO between two groups (P < 0.001). In univariate analysis, apoO correlated significantly with lg(hsCRP) (r = 0.48, P < 0.001) in ACS patients. Notably, no significant correlation between apoO and other lipid parameters was observed. Logistic regression analysis showed that plasma apoO level was an independent predictor of ACS (OR = 5.61, 95% CI 2.16–14.60, P < 0.001). In conclusion, apoO increased in ACS patients, and may be regarded as an independent inflammatory predictor of ACS patients.
first_indexed 2024-12-17T23:34:53Z
format Article
id doaj.art-8616d4e80a104caba3404aa87913f0e0
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-17T23:34:53Z
publishDate 2012-09-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-8616d4e80a104caba3404aa87913f0e02022-12-21T21:28:35ZengElsevierJournal of Lipid Research0022-22752012-09-0153919521957Plasma apolipoprotein O level increased in the patients with acute coronary syndromeBi-lian Yu0Chen-lu Wu1Shui-ping Zhao2Department of Cardiology, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, PR ChinaDepartment of Cardiology, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, PR ChinaTo whom correspondence should be addressed. e-mail: zhaosp@medmail.com.cn.; To whom correspondence should be addressed. e-mail: zhaosp@medmail.com.cn.; Department of Cardiology, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, PR ChinaApolipoprotein (apo) O is a novel apolipoprotein that is present predominantly in high density lipoprotein (HDL). However, overexpression of apoO does not impact on plasma HDL levels or functionality in human apoA-I transgenic mice. Thus, the physiological function of apoO is not yet known. In the present study, we investigated relationships between plasma apoO levels and high-sensitive C-reactive protein (hs-CRP) levels, as well as other lipid parameters in healthy subjects (n = 111) and patients with established acute coronary syndrome (ACS) (n = 50). ApoO was measured by the sandwich dot-blot technique with recombinant apoO as a protein standard. Mean apoO level in healthy subjects was 2.21 ± 0.83 µg/ml whereas it was 4.94 ± 1.59 µg/ml in ACS patients. There were significant differences in plasma level of apoO between two groups (P < 0.001). In univariate analysis, apoO correlated significantly with lg(hsCRP) (r = 0.48, P < 0.001) in ACS patients. Notably, no significant correlation between apoO and other lipid parameters was observed. Logistic regression analysis showed that plasma apoO level was an independent predictor of ACS (OR = 5.61, 95% CI 2.16–14.60, P < 0.001). In conclusion, apoO increased in ACS patients, and may be regarded as an independent inflammatory predictor of ACS patients.http://www.sciencedirect.com/science/article/pii/S0022227520418371apolipoproteinsatherosclerosishigh density lipoproteininflammationlipoproteins
spellingShingle Bi-lian Yu
Chen-lu Wu
Shui-ping Zhao
Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
Journal of Lipid Research
apolipoproteins
atherosclerosis
high density lipoprotein
inflammation
lipoproteins
title Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
title_full Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
title_fullStr Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
title_full_unstemmed Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
title_short Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
title_sort plasma apolipoprotein o level increased in the patients with acute coronary syndrome
topic apolipoproteins
atherosclerosis
high density lipoprotein
inflammation
lipoproteins
url http://www.sciencedirect.com/science/article/pii/S0022227520418371
work_keys_str_mv AT bilianyu plasmaapolipoproteinolevelincreasedinthepatientswithacutecoronarysyndrome
AT chenluwu plasmaapolipoproteinolevelincreasedinthepatientswithacutecoronarysyndrome
AT shuipingzhao plasmaapolipoproteinolevelincreasedinthepatientswithacutecoronarysyndrome